Previous 10 | Next 10 |
GlobeNewswire news releases related Globenewswire news releases and Globenewswire press releases from 11/13/19 04:05:00 on US and Canada Markets.
ALPHARETTA, Ga., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that Management will ...
DRAPER, Utah, Nov. 13, 2019 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), a leading provider of health savings accounts (HSAs) and complementary consumer-directed benefits (“CDBs”), today announced its plans...
LONDON, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer, today announced that Dr. Christian Itin, chairman and chief executive office...
Nine-Month Results – 2019 vs. 2018 Total revenue increased 19% to $38.1 million from $32.0 million Well enhancement service revenue up 19% to $34.9 million from $29.5 million Water transfer service revenue up 25% to $3.2 million from $2.6 million ...
TEMPLE CITY, Calif., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ: FLGT) (“Fulgent Genetics” or the “Company”), a provider of comprehensive genetic testing and Next Generation Sequencing (NGS) solutions, today announced that it has commenced an unde...
AUSTIN, Texas, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Ideal Power Inc. (NASDAQ: IPWR), pioneering the development and commercialization of highly efficient and broadly patented B-TRAN™ bi-directional power switches, reported results for its third quarter ended September 30, 2019....
AURORA, Ill., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Westell Technologies, Inc. (NASDAQ: WSTL), a leading provider of high-performance network infrastructure solutions, today announced results for its fiscal 2020 second quarter ended September 30, 2019 (2Q20). Management will host...
Opens Phase III Global Biliary Tract Cancer Study (NuTide:121) with Potential for Accelerated Approval Filing Focusing Resources on Key Value-Driving Programs of Biliary Tract Cancer and Colorectal Cancer Cash and Cash Equivalents to Fund Operations into the Second Half of 20...
NEW YORK, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the...
SIOUX FALLS, S.D., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Raven Industries, Inc. (the Company; NASDAQ:RAVN) announced today that it has completed the acquisition of majority ownership of DOT Technology Corp. (DOT®), a leader in autonomous agriculture solutions. The investment ...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
8.61%Change Percent:
AGBA Acquisition Limited Company Name:
AGBA Stock Symbol:
NASDAQ Market: